Skip to content

Limb-Girdle Video Assessment

Limb-Girdle Video Assessment Concept Elicitation and Feasibility Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05528757
Enrollment
45
Registered
2022-09-06
Start date
2022-06-20
Completion date
2022-11-02
Last updated
2023-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Limb-Girdle Muscular Dystrophy ; Subtypes 2A, 2B, and 2I

Keywords

Limb-Girdle Muscular Dystrophy, Outcome Measure Development, Video Captures, Remote Assessment, Concept Elicitation, Feasibility Testing

Brief summary

The purpose of this study is to develop a new remote-based video assessment outcome measure for Limb-Girdle Muscular Dystrophy (LGMD) trials. The overall objectives for this study are: 1. Identify domains and tasks meaningful to participants with a Limb-Girdle Muscular Dystrophy (LGMD) for development of the LGVA, including considerations for subtype heterogeneity and functional subgroup branching; 2. Determine the feasibility and reliability of the LGVA with test-retest of the LGVA Video Capture Manual; 3. Assess and refine the LGVA Video Capture Manual to ensure standardization and incorporate feedback from participants; 4. Collect source material videos using the LGVA Video Capture Manual to support the development of scorecards for the LGVA.

Detailed description

The purpose of this study is to gain insight from people living with an LGMD and gather source material videos to develop and test Limb-Girdle Video Assessment (LGVA), a new outcome measure designed to assess changes in functional abilities of participants in LGMDs clinical trials. The LGVA is being designed as a remote video capture to assess nuanced changes in compensatory movement patterns over time. This study involves two stages. In the concept elicitation stage, the tasks for the LGVA Video Capture Manual will be finalized based on feedback from participants living with an LGMD 2A, 2B, or 2I in various stages of disease progression. After finalizing the LGVA Video Capture Manual, source material videos will be collected to evaluate the feasibility and appropriateness of the LGVA tasks, standardize capture procedures, and inform the development of scorecards for the LGVA.

Interventions

None listed

Sponsors

Coalition to Cure Calpain 3 (C3)
CollaboratorUNKNOWN
Jain Foundation
CollaboratorOTHER
The Emmes Company, LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Person with confirmed diagnosis of an LGMD 2A, 2B, or 2I * ≥14 years of age at the timing of consent (if age 14 - 17, consent from the parent/ legal guardian is also needed) * Able to read, speak, and understand English * Residing in the USA * Willing and able to complete an electronic survey, which includes questions about personal characteristics and medical history as well as review of tasks * Willing and able to discuss their experiences as a person living with an LGMD in a group setting * Willing and able to complete 2 rounds of video capture following instructions in the LGVA Video Capture Manual in a 30-day period * Willing and able to complete an exit interview to discuss their experiences capturing and recording videos with the LGVA Video Capture Manual

Design outcomes

Primary

MeasureTime frameDescription
Assessing the fluctuation of movement abilities of LGMDs patients via remote video capture.January 2023 - March 2023Using the newly developed LGVA Video Capture Manual, participants are asked to record two sets of videos of them performing assigned tasks. Participants will have one week to complete each round of video capture, with approximately one month between each round. Videos will be captured remotely and uploaded through a secure platform.

Secondary

MeasureTime frameDescription
Task Selection SurveyAugust 2022 - September 2022Electronic survey asking LGMDs patients about tasks and activities they perform in their daily life, and if/ how these are impacted by their LGMD symptoms.
Focus GroupSeptember 2022 - October 2022Small group discussion of participants with similar functional abilities to discuss the progression of symptoms and heterogeneity among subtypes.
Exit InterviewJanuary 2023 - March 2023After the feasibility video captures are complete, participants are asked about their experiences using the LGVA Video Capture Manual and the recording procedures.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026